Access to Care (R95)

• UPDATE ADMISSION AND DISCHARGE POLICIES
  R95 Admission Policy (2-A) – only for agencies that DID NOT participate in FY23-24
  Designed to ensure more flexible admission policies that allow for enrollment of individuals at different points of their recovery. Agencies that did not participate in FY 23-24 may complete. Submit compliant admission policy deliverable for approval by 10/30/24.

  • • R95 Admission Policy Required Language (2-A) (pdf)
    • R95 Admission Policy Required Language (2-A)
      Due 10/30/24
    • Invoice-Reaching the 95% (R95)
      Due 10/30/24

  R95 Discharge Policy (2-B) – only for agencies that DID NOT participate in FY23-24
  Designed to ensure more flexible discharge policies that do not result in automatic discharge if clients use substances during a treatment episode and facilitate a culture of treating SUDs as chronic conditions. Agencies that did not participate in FY 23-24 may complete. Submit compliant discharge policy deliverable for approval by 10/30/24.

  • • R95 Discharge Policy (2-B) (pdf)
    • R95 Discharge Policy (2-B)
      Due 10/30/24
    • Invoice-Reaching the 95% (R95)
      Due 10/30/24

  R95 Training Presentation (2-C) – only for agencies that DID NOT participate in FY23-24
  Development of training for agency staff to ensure understanding and adoption of lower barrier care changes in admission policies (2-A), discharge policies (2-B) and toxicology (2-E). Agencies that did not participate in FY 23-24 may complete. Submit compliant training presentation for approval by deliverable date: 11/30/24.

  • • R95 Admission/Discharge Policy Training Presentation Required Language (2-C) (pdf)
    • R95 Admission/Discharge Policy Training Presentation Required Language (2-C)
      Due 11/30/24
    • Invoice-Reaching the 95% (R95)
      Due 11/30/24

  R95 Admission Agreement (2-D)
  To ensure that patient-facing admission agreement aligns with the updated R95 admission and discharge policies and that current and prospective patients experience how the provider has embraced and actualized lower barrier care. Any agency that has satisfied pre-requisites (R95 Admission Policy (2-A), R95 Discharge Policy (2-B) and R95 Training Presentation (2-C) may participate in new effort automatically). Submit compliant admission agreement deliverable for approval by 12/31/24.

  • • Invoice-Reaching the 95% (R95)
      Due 12/31/24
    • Admission Agreement for Patient Signature Required Language (2-D) (pdf)
    • Admission Agreement for Patient Signature Required Language (2-D)
      Due 12/31/24

  R95 Toxicology Policy and Patient Agreement (2-E)
  To ensure that patient-facing toxicology agreement aligns with the updated R95 admission and discharge policies and that current and prospective patients experience how the provider has embraced and actualized lower barrier care. Any agency that has satisfied pre-requisites (R95 Admission Policy (2-A), R95 Discharge Policy (2-B) and R95 Training Presentation (2-C)) may participate in new effort automatically) Submit compliant toxicology policy and patient agreement for approval by deliverable due date of 12/31/24.

  • • Invoice-Reaching the 95% (R95)
      Due 12/31/24
    • Toxicology Policy and Patient Agreement Required Language (2-E) (pdf)
    • Toxicology Policy and Patient Agreement Required Language (2-E)
      Due 12/31/24

  R95 Staff Training Verification (2-F)
  To ensure that managers and staff understand and effectively implement their updated policies and agreements, and what is expected of them as it relates to patients with minimum 85% participation in training. Any agency that has satisfied pre-requisites (R95 Admission Policy (2-A), R95 Discharge Policy (2-B) and R95 Training Presentation (2-C) may participate in new effort automatically). Submit verifications: A) Attestation of R95 Training Protocols for Staff and B) Verification of (minimum 85%) practitioner training participation between 7/1/24 and deliverable due date of 3/31/25.

  • • R95 Staff Training Attestation Deliverable A
    • R95 Staff Training Verification Deliverable B
    • Invoice-Reaching the 95% (R95) (New - March 205 )
      Due 03/31/25
• SERVICE DESIGN FOR LOWER BARRIER CARE
  Service Design Follow-Up Implementation Process Improvement (2-G) – only for agencies with an approved Implementation Plan in FY 23-24
  To support providers in completion of their Service Design Process Improvement goals. Only Providers whose Service Design Implementation Plan was approved in Year 1 may participate in this category. Submit the Change Project Plan demonstrating completion of process improvement activities associated with your Year 1 Service Design Implementation Plan for approval by 3/31/25 to avoid recoupment if start-up funds received. Submit with Invoice – R95 for deliverable payment if start-up funds not previously requested. Expenditure verification is not required.

  • • Invoice-Reaching the 95% (R95)-Start Up Funds
      Due 09/15/24
    • Change Project Plan (2-G) (New - March 2025)
      Due 03/31/25
    • Invoice: R95 (Deliverable based) (New - March 2025)
      Due 03/31/25

  Customer Walk-Through (2-H) – only for agency sites that DID NOT participate in FY23-24
  To support adapting their program services to set expectations and standards for optimally serving the R95 population an inviting intake process, and ensuring a welcoming and professional treatment environment for all patients. Submit forms demonstrating completion of customer experience assessment and walk-through results for approval. Available to providers who did not participate in Customer Walk Throughs in Year 1 (FY 23-24). Submit deliverable forms one per DMC certified/licensed and executed contract site by 1/31/25.

  • • Customer Walk-Through Guidance and Deliverable Templates (PDF)
      Due 01/31/25
    • Invoice-Reaching the 95% (R95)
      Due 01/31/25

  Implementation/Investment Plan (2-I) – only for agencies that DID NOT participate in FY23-24
  Providers should articulate expectations to patients and staff to ensure a positive patient experience and develop a plan to monitor the implementation of new changes to ensure appropriate implementation and adoption. Available to providers who did not participate in Service Design Implementation Plan in Year 1 (FY 23-24). Submit completed Service Design Expectation Deliverable Form demonstrating completion of improvement and investment plan for approval- one per treatment agency- by 3/31/25

  • • Implementation/Investment Plan Template (2-I) (PDF) (New - March 2025)
      Due 03/31/25
    • Invoice-Reaching the 95% (R95) (New - March 2025)
      Due 03/31/25
• BIDIRECTIONAL REFERRALS- SUD TREATMENT & HARM REDUCTION SERVICES
  Treatment Agency Staff Participation in Harm Reduction Trainings (2-J)
  Supports providers in efforts to optimize bidirectional referral partnerships between treatment sites and harm reduction syringe service programs (SSPs). Submit verifications: A) Attestation of Harm Reduction Training Protocols for Staff and B) Verification of (minimum 85%) practitioner training participation between 7/1/24 and deliverable due date of 3/31/25.

  • • Treatment Agency Staff Participation In Harm Reduction Trainings – Attestation And Verification (New - March 205 )
      Due 03/31/25
    • Invoice-Reaching the 95% (R95) (New - March 205 )
      Due 03/31/25

  Harm Reduction Verified Admissions (2-K)
  Providers should utilize Admission verification from harm reduction SSP using CalOMS Principal Source of Referral item 3.2 indicating referral from harm reduction SSP through 3/31/25. SAPC will internally verify each agency’s number of verified admissions from harm reduction SSPs and process payment. No Invoice Required.